Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÖzkay, Ümide Demir
dc.contributor.authorCan, Özgür Devrim
dc.contributor.authorSağlık, Begüm Nurpelin
dc.contributor.authorÇevik, Ulviye Acar
dc.contributor.authorLevent, Serkan
dc.contributor.authorÖzkay, Yusuf
dc.contributor.authorAtlı Eklioğlu, Özlem
dc.date.accessioned2019-10-19T14:43:50Z
dc.date.available2019-10-19T14:43:50Z
dc.date.issued2016
dc.identifier.issn0960-894X
dc.identifier.issn1464-3405
dc.identifier.urihttps://dx.doi.org/10.1016/j.bmcl.2016.10.041
dc.identifier.urihttps://hdl.handle.net/11421/13230
dc.descriptionWOS: 000388251400004en_US
dc.descriptionPubMed ID: 27789142en_US
dc.description.abstractIn the current study, 14 new benzothiazole-piperazine compounds were designed to meet the structural requirements of acetylcholine esterase (AChE) inhibitors. The target compounds were synthesised in three steps. Structures of the newly synthesised compounds (7-20) were confirmed using IR, H-1 NMR, C-13 NMR, and HRMS methods. The inhibitory potential of the compounds on AChE (E.C.3.1.1.7, from electric eel) was then investigated. Among the compounds, 19 and 20 showed very good activity on AChE enzyme. Kinetics studies were performed to observe the effects of the most active compounds on the substrate-enzyme relationship. Cytotoxicity studies, genotoxicity studies, and theoretical calculation of pharmacokinetics properties were also carried out. The compounds 19 and 20 were found to be nontoxic in both of the toxicity assays. A good pharmacokinetics profile was predicted for the synthesised compounds. Molecular docking studies were performed for the most active compounds, 19 and 20, and interaction modes with enzyme active sites were determined. Docking studies indicated a strong interaction between the active sites of AChE enzyme and the analysed compoundsen_US
dc.description.sponsorshipAnadolu University Scientific Projects Fund [1605S314]en_US
dc.description.sponsorshipThis study was financially supported by Anadolu University Scientific Projects Fund, Project No: 1605S314.en_US
dc.language.isoengen_US
dc.publisherPergamon-Elsevier Science LTDen_US
dc.relation.isversionof10.1016/j.bmcl.2016.10.041en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAlzheimer Diseaseen_US
dc.subjectAcetylcholinesteraseen_US
dc.subjectBenzothiazoleen_US
dc.subjectPiperazineen_US
dc.subjectDockingen_US
dc.titleDesign, synthesis, and AChE inhibitory activity of new benzothiazole-piperazinesen_US
dc.typearticleen_US
dc.relation.journalBioorganic & Medicinal Chemistry Lettersen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmakoloji Anabilim Dalıen_US
dc.identifier.volume26en_US
dc.identifier.issue22en_US
dc.identifier.startpage5387en_US
dc.identifier.endpage5394en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.contributor.institutionauthorÖzkay, Ümide Demir
dc.contributor.institutionauthorCan, Özgür Devrim
dc.contributor.institutionauthorSağlık, Begüm Nurpelin
dc.contributor.institutionauthorÖzkay, Yusuf
dc.contributor.institutionauthorAtlı Eklioğlu, Özlem


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster